New Therapeutic Options for Treatment of Multi-drug Resistant Gram-negative Microorganisms

Journal Title: Journal of Ankara University Faculty of Medicine - Year 2020, Vol 73, Issue 2

Abstract

Recently, antibiotic resistance in gram-negative microorganisms has been increased. While multi-drug resistant and extensively-drug resistant gram-negative strains are the most common cause of healthcare-associated infections, and they are related with high morbidity and mortality. This increase in antimicrobial resistance results in frequently inappropriate use of antibiotics. Effective antibiotic options are decreasing, in proportion to this, new antibiotic development is less than the resistance. However, datas related with on some newly developed and developing antibiotics, which are included in the old antimicrobial classes, are increasing. In this review, it is aimed to present new antibiotic options that are being used and are being developed for the treatment of infections which are caused by antibiotic resistant gram-negative microorganisms are presented. Double carbapenem therapy has been studied and evaluated as a treatment option for carbapenemase producing Enterobacteriaceae. Ceftazidime -avibactam, meropenem - vaborbactam and ceftolozan - tazobactam, which are new beta-lactam beta-lactamase inhibitors, will soon appear to be included in daily clinical practice. In addition, imipenem/cilastatin - relebactam, eravacycline, plasomycin and cefiderocol are new antibiotics that are still being studied for efficacy and safety. Although, with all these new treatment options, we get stronger against infections that are caused by drug resistant gram-negatives, the best way to combat drug resistant microorganisms is to prevent the resistance and spread of resistant clones the rational use of antibiotics.

Authors and Affiliations

Müge Ayhan

Keywords

Related Articles

Investigation of Molecular Changes in RAS/RAF/MEK/MAPK Pathway in Serous Adenocarcinomas and Serous Borderline Tumors of Ovary

Objectives: To investigate MAP Kinase (p38), c-Fos, c-Jun and c-Myc; in RAS/RAF/MEK/MAPK pathway by immunohistochemically in high grade serous adenocarcinomas, serous borderline tumors and benign lesions of the ovary. M...

Flexible Bronchoscopy in Childhood: 5-year Single-center Experience

Objectives: Flexible fiberoptic bronchoscopy (FB) is one of the methods used for the diagnosis of childhood respiratory diseases. This diagnostic method allows the examination of the nose, pharynx, larynx and tracheobron...

Traumatic Wound Infection Caused By Bacillus Cereus

Bacillus cereus is an aerobic, endospore-forming Gram-positive rod found widely in nature, including soil, dust and mud, rotting organic matter, fresh and salt water, vegetables and fomites. When isolated from clinical s...

Correlation of Computed Tomography Findings with Histopathology in Small Lung Adenocancer

Objectives: To analyse the correlation between computed tomography (CT) features and histopathological findings of small lung adenocancers using the International Association for the Study of Lung Cancer/American Thoraci...

Retrospective Evaluation of Surgically Treated Patients with Myelomeningocele

Objectives: Neural tube defects are the most common congenital malformation of the central nervous system. Identification, classification and treatment of spinal malformations are important in terms of prognosis of the n...

Download PDF file
  • EP ID EP684812
  • DOI 10.4274/atfm.galenos.2020.92408
  • Views 204
  • Downloads 0

How To Cite

Müge Ayhan (2020). New Therapeutic Options for Treatment of Multi-drug Resistant Gram-negative Microorganisms. Journal of Ankara University Faculty of Medicine, 73(2), -. https://europub.co.uk/articles/-A-684812